Russo I, Del Mese P, Doronzo G, Mattiello L, Viretto M, Bosia A, Anfossi G, Trovati M
Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano (TO), Italy.
Endocrinology. 2008 Apr;149(4):1480-9. doi: 10.1210/en.2007-0920. Epub 2007 Dec 13.
Some in vivo and ex vivo studies demonstrated a resistance to the vasodilating effects of nitric oxide (NO) in insulin-resistant states and, in particular, obese Zucker rats (OZR). To evaluate the biochemical basis of this phenomenon, we aimed to identify defects of the NO/cGMP/cGMP-dependent protein kinase (PKG) pathway in cultured vascular smooth muscle cells (VSMCs) from OZR and lean Zucker rats (LZR) by measuring: 1) NO donor ability to increase cGMP in the absence and presence of inhibitors of soluble guanylate cyclase (sGC) and phosphodiesterases (PDEs); 2) NO and cGMP ability to induce, via PKG, vasodilator-stimulated phosphoprotein (VASP) phosphorylation at serine 239 and PDE5 activity; 3) protein expression of sGC, PKG, total VASP, and PDE5; 4) superoxide anion concentrations and ability of antioxidants (superoxide dismutase+catalase and amifostine) to influence the NO/cGMP/PKG pathway activation; and 5) hydrogen peroxide influence on PDE5 activity and VASP phosphorylation. VSMCs from OZR vs. LZR showed: 1) baseline cGMP concentrations higher, at least in part owing to reduced catabolism by PDEs; 2) impairment of NO donor ability to increase cGMP, even in the presence of PDE inhibitors, suggesting a defect in the NO-induced sGC activation; 3) reduction of NO and cGMP ability to activate PKG, indicated by the impaired ability to phosphorylate VASP at serine 239 and to increase PDE5 activity via PKG; 4) similar baseline protein expression of sGC, PKG, total VASP, and PDE5; and 5) higher levels of superoxide anion. Antioxidants partially prevented the defects of the NO/cGMP/PKG pathway observed in VSMCs from OZR, which were reproduced by hydrogen peroxide in VSMCs from LZR, suggesting the pivotal role of oxidative stress.
一些体内和体外研究表明,在胰岛素抵抗状态下,尤其是肥胖 Zucker 大鼠(OZR),对一氧化氮(NO)的血管舒张作用存在抵抗。为了评估这一现象的生化基础,我们旨在通过测量以下指标,来鉴定 OZR 和瘦 Zucker 大鼠(LZR)培养的血管平滑肌细胞(VSMC)中 NO/cGMP/依赖 cGMP 的蛋白激酶(PKG)途径的缺陷:1)在存在和不存在可溶性鸟苷酸环化酶(sGC)抑制剂和磷酸二酯酶(PDE)抑制剂的情况下,NO 供体增加 cGMP 的能力;2)NO 和 cGMP 通过 PKG 诱导血管舒张刺激蛋白(VASP)丝氨酸 239 位点磷酸化和 PDE5 活性的能力;3)sGC、PKG、总 VASP 和 PDE5 的蛋白表达;4)超氧阴离子浓度以及抗氧化剂(超氧化物歧化酶 + 过氧化氢酶和氨磷汀)影响 NO/cGMP/PKG 途径激活的能力;5)过氧化氢对 PDE5 活性和 VASP 磷酸化的影响。与 LZR 的 VSMC 相比,OZR 的 VSMC 表现出:1)基础 cGMP 浓度更高,至少部分归因于 PDE 分解代谢减少;2)即使存在 PDE 抑制剂,NO 供体增加 cGMP 的能力仍受损,提示 NO 诱导的 sGC 激活存在缺陷;3)NO 和 cGMP 激活 PKG 的能力降低表现为,VASP 丝氨酸 239 位点磷酸化能力受损以及通过 PKG 增加 PDE5 活性的能力受损;4)sGC、PKG、总 VASP 和 PDE5 的基础蛋白表达相似;5)超氧阴离子水平更高。抗氧化剂部分预防了 OZR 的 VSMC 中观察到的 NO/cGMP/PKG 途径缺陷,而 LZR 的 VSMC 中过氧化氢可重现这些缺陷,提示氧化应激起关键作用。